The feasibility of HIV vaccine efficacy trials among Russian injection drug users.

Journal Article (Journal Article)

IDU exposure remains a primary driver of the Russian HIV epidemic, and recent incidence data provide little evidence that this epidemic is slowing. While there are multiple important challenges that need to be further explored before starting vaccine trials, most importantly access to evidence-based drug treatment services for trial participants, the current context of high HIV incidence and low genetic diversity of HIV strains, suggests the need for intensified prevention strategies and supports the feasibility of mounting efficacy trials of HIV vaccines among IDUs in the Russian Federation.

Full Text

Duke Authors

Cited Authors

  • Beyrer, C; Baral, S; Shaboltas, A; Dukhovlinova, E; Masharsky, A; Verevochkin, S; Latkin, C; Heimer, R; Hoffman, I; Kozlov, A

Published Date

  • October 10, 2007

Published In

Volume / Issue

  • 25 / 41

Start / End Page

  • 7014 - 7016

PubMed ID

  • 17707960

Pubmed Central ID

  • PMC3747029

International Standard Serial Number (ISSN)

  • 0264-410X

Digital Object Identifier (DOI)

  • 10.1016/j.vaccine.2007.07.028


  • eng

Conference Location

  • Netherlands